Skip to content
value.today

Simulations Plus, Inc.: valuation

What the market value assumes, and what the company's own statements and its peers' prices would put it at. Every assumption is yours to change.

Cash-flow value and what the price assumes

$M

Average of FY2023–FY2025 (cash from operations less capital spending), from the statements below.

%

Starts at revenue growth over the last three years, 13.7% a year (statements).

%

US Treasury 10-year yield on Nov 13, 2026: 5.15% (US Treasury).

%

Your assumption: the extra yearly return you want for holding shares rather than Treasuries. 5% is a round starting figure, not data.

%

Your assumption: long-run growth, usually near inflation. It must stay below the discount rate.

$M

Debt or cash not on file: 0 to start with.

What today's price assumes

The price's implied growth cannot be worked out with these figures (it needs a positive cash flow, a market value and a discount rate above long-run growth).

Cash-flow value of the shares
$521 M
Value of the whole business
$521 M
before net debt
Value from after year 10
61%
of the business value

Against the market value, for other rates

Cash-flow value of the shares as a percentage above or below today's market value; your inputs in the middle.

Sensitivity of the cash-flow value to the discount rate and the growth rate
Discount rate ↓ / growth →8.67%11.17%13.67%16.17%18.67%
8.15%—————
9.15%—————
10.15%—————
11.15%—————
12.15%—————

On one scale

Bars: from the 25th to the 75th percentile multiple of the peers, the line at the median; dot: the cash-flow value with your inputs.

Price to salesPrice to sales of Healthcare Information Services: $98 M to $519 M, median $133 MPrice to bookPrice to book of Healthcare Information Services: $152 M to $577 M, median $238 MCash-flow value$0 M$156 M$311 M$467 M$623 M

Your own DCF model

A full discounted-cash-flow model of Simulations Plus, Inc., started from its filings: revenue growth and margins year by year, bear, base and bull cases, the WACC and its parts, sensitivity tables and a value per share against the dated market price. Save it, share it with your team or by a read-only link.

Open the DCF model

Against the industry Healthcare Information Services

Multiples of its companies with a market value at most 60 days old, times Simulations Plus, Inc.'s own figures of FY2025.

Values from the peers' multiples
MultiplePeers (25th / median / 75th)Simulations Plus, Inc.Applied toValue (25th to 75th)Companies
Price to sales1.2× / 1.7× / 6.6×—revenue $79 M$98 M to $519 M15
Price to book1.2× / 1.9× / 4.6×—book equity $125 M$152 M to $577 M15

Peers' multiples from the distributions by industry; the company's figures from its statements below. A multiple says what similar companies cost, not what this one is worth.

Against its own history

Simulations Plus, Inc.'s multiples at each month end with a market cap on file, Jan 2020 to Sep 2026, each against its own median.

P/E

46.0×

Now below its median of 62.0×, in the bottom quarter of its range; range 45.7× to 153.9× over 17 months.

0×38×77×115×154×2020202120222023202420252026P/E 46×Median 62×

Price to sales

4.5×

Now close to its median of 4.6×; range 3.0× to 34.5× over 29 months.

0×9×17×26×35×2020202120222023202420252026Price to sales 5×Median 5×

Price to book

3.0×

Now close to its median of 3.0×; range 1.5× to 13.3× over 29 months.

0×3×7×10×13×2020202120222023202420252026Price to book 3×Median 3×

as of Sep 28, 2026. Market caps: the dated values on file since 2020, and in between the SEC's fails-to-deliver closing price times the share count on the latest 10-K or 10-Q cover. Each month divides by the last twelve months' results that had been published by then (a quarter 45 days after it ended, a fiscal year 60 days after), so the past is not read with figures that came out later; months with a loss give no P/E. Newest month: Sep 28, 2026.

The statements it starts from

USD millions at each year's exchange rate; free cash flow = cash from operations less capital spending.

Figures from the annual statements
Fiscal yearRevenueNet incomeCash from operationsCapital spendingFree cash flowNet debtSource
FY2025to Aug 31, 2025$79 M$-65 M$18 M$1 M$17 M—SEC annual report (10-K, 20-F)
FY2024to Aug 31, 2024$70 M$10 M$13 M$1 M$13 M—SEC annual report (10-K, 20-F)
FY2023to Aug 31, 2023$60 M$10 M$22 M$0 M$21 M—SEC annual report (10-K, 20-F)
FY2022to Aug 31, 2022$54 M$12 M$18 M$1 M$17 M—SEC annual report (10-K, 20-F)
FY2021to Aug 31, 2021$46 M$10 M$19 M$2 M$18 M—SEC annual report (10-K, 20-F)
FY2020to Aug 31, 2020$42 M$9 M$11 M$0 M$11 M—SEC annual report (10-K, 20-F)

Each figure as filed; the full statements with every line and its filing are on the company page. Market value not on file.

How it is worked out: the cash-flow value is free cash flow grown at the first-stage rate for the years chosen, then at the long-run rate for ever, each year discounted at the risk-free rate plus the equity risk premium, less net debt. What the price assumes is the first-stage growth that makes that value equal today's market value. The starting cash flow, growth and net debt come from the statements; the risk-free rate from the US Treasury; the premium and the long-run growth are assumptions and are labelled so. This is arithmetic on reported figures, not advice.